A recent analysis of data from the UK Biobank involving 202,171 individuals has revealed potential associations between dietary one-carbon metabolism (OCM) nutrients and the incidence of Parkinson’s disease (PD). The study utilized repeated 24-hour dietary recalls to assess intake of key OCM nutrients—methionine, folate, vitamin B6, and vitamin B12—and tracked PD incidence through validated ICD-10 codes over a median follow-up of 12.27 years. Notably, participants in the highest quartile of intake for these nutrients exhibited a significantly lower risk of developing PD, with hazard ratios ranging from 0.71 to 0.83 compared to those in the lowest quartile.

These findings underscore the therapeutic potential of OCM nutrients in mitigating PD risk, particularly in genetically stratified groups. For instance, folate intake was inversely associated with PD risk in individuals with low genetic risk (HR = 0.65), while vitamin B12 showed a protective effect in those with high genetic risk (HR = 0.78). Additionally, vitamin B6 consistently demonstrated an inverse relationship with PD risk across both genetic strata, suggesting a robust protective role regardless of genetic predisposition.

The implications of this research are significant for the field of aging and neurodegenerative disease. It suggests a potential shift in focus towards dietary interventions as a means of preventive strategy against PD, particularly in at-risk populations. This could accelerate the development of nutritional guidelines and therapeutic approaches aimed at enhancing healthspan through targeted dietary modifications, emphasizing the need for further investigation into the independent contributions of dietary and genetic factors in PD pathogenesis.

Source: academic.oup.com